Market & Alt Data
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-17 | 2026-09-18 | Russell Thomas | Chief Legal Officer | Sale | 50.0K | $6.51 | $326K | 471.5K | View | |
| 2026-09-17 | 2026-09-17 | Locke Mark | Director & Chief Executive Officer | Sale | 50.0K | $6.54 | $327K | 19.38M | View | |
| 2026-09-16 | 2026-09-17 | Locke Mark | Director & Chief Executive Officer | Sale | 272.6K | $6.56 | $1.79M | 19.43M | View | |
| 2026-09-15 | 2026-09-17 | Locke Mark | Director & Chief Executive Officer | Sale | 477.4K | $6.58 | $3.14M | 19.70M | View |
Informational purposes only, not investment advice.
tormere.com/research/GENI · generated 2026-11-05
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-09-17 | Russell Thomas | S | 50,000 | $325,565 |
| 2026-09-17 | Locke Mark | S | 50,000 | $327,050 |
| 2026-09-16 | Locke Mark | S | 272,551 | $2M |
| 2026-09-15 | Locke Mark | S | 477,449 | $3M |
Tormere — informational purposes only, not investment advice.